Use of medicinal plants among patients with diabetes mellitus type 2 in Morelos, Mexico

Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas

Volumn 8, Issue 5, 2009, Pages 380-388

  Romero Cerecero, Ofelia ^a   Reyes Morales, Hortensia ^b   Aguilar Santamaría, Lucía ^a   Huerta Reyes, Maira ^a   Tortoriello Garcia, Jaime ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

Complementary therapy; Medicinal plants; Mexico; Type 2 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; BRICKELLIA CAVANILLESII EXTRACT; GLIBENCLAMIDE; OPUNTIA EXTRACT; PLANT EXTRACT; TECOMA STANS EXTRACT; UNCLASSIFIED DRUG;

ADULT; ALTERNATIVE MEDICINE; ARTICLE; BRICKELLIA CAVANILLESII; DRUG USE; DRUG UTILIZATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICINAL PLANT; MEXICO; NON INSULIN DEPENDENT DIABETES MELLITUS; OPUNTIA; PRESCRIPTION; PRIMARY MEDICAL CARE; QUESTIONNAIRE; TECOMA STANS;

OPUNTIA;

EID: 77749301505     PISSN: None     EISSN: 07177917     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Aguilar A, Camacho R, Chino S, Jáquez P, López ME. 1994. Herbario medicinal del Instituto Mexicano del Seguro Social. Instituto Mexicano del Seguro Social, México, 353 p.
2. Aguilar Salinas C, Rojas R, Gómez Pérez FJ, García E, Valles V, Ríos Torres JM, Franco A, Oláiz,G, Sepúlveda J, Rull J. 2002. Prevalence and characteristics of early-onset type 2 diabetes in Mexico. Am J Med 113: 569-574.
3. Aguilar-Santamaría L, Ramírez G, Nicasio P, Alegría-Reyes C, Herrera-Arellano A. 2009. Antidiabetic activities of Tecoma stans (L.) Juss. ex Kunth. J Ethnopharmacol doi:10.1016/j.jep. 2009.04.
4. Andrade C, Heinrich M. 2005. Mexican plants with hypoglycaemic effect used in the treatment of diabetes. J Ethnopharmacol 99: 325-348.
5. Bailey CJ, Day C. 1989. Traditional plant medicines as treatments for diabetes. Diabetes Care 12: 553-564.
6. Baldé NM, Youla A, Baldé MD, Kaké A, Diallo MM, Baldé MA, Maugendre D. 2006. Herbal medicine and treatment of diabetes in Africa: an example from Guinea. Diabetes Metab 32: 171-175.
7. CONABIO/UAEM. 2004. La diversidad biológica en Morelos: estudio del estado. Contreras-MacBeath TJ, Boyás JC, Jaramillo F. Comisión Nacional para el conocimiento y uso de la Biodiversidad. Universidad Autónoma del estado de Morelos, México.
8. Costantino L, Raimondi L, Pirisino R, Brunetti T, Pessotto P, Giannessi F, Lins AP, Barlocco D, Antolini L, El-Abady SA. 2003. Isolation and pharmacological activities of the Tecoma stans alkaloids. Il Farmaco 58: 781-785.
9. Eisenberg DM, Davis RB, Ettner SL, Appler S, Wilkey S, Van Rompay M, Kessler RC. 1998. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 280: 1569-1575.
10. Ernst E. 2007. Herbal medicines: balancing benefits and risk. Novartis Found Symp 282: 154-167.
11. Frati M, Fernández H, Bañales H, Ariza A. 1983. Disminución de glucosa e insulina sanguíneas por nopal (Opuntia sp.). Arch Invest Med (Méx) 14: 269-274.
12. Heinrich M, Robles M, West JE, Ortíz de Montellano Br Rodriguez. 1998. Ethnopharmacology of Mexican Asteraceae (Compositae). Annu Rev Pharmacol Toxicol 38: 539-565
13. Hernández-Galicia E, Aguilar-Contreras A, Aguilar- Santamaría L, Román-Ramos R, Chávez-Miranda AA, García-Vega LM, Flores-Sáenz JL, Alarcón-Aguilar FJ. 2002. Studies on hypoglycemic activity of Mexican medicinal plants. Proc West Pharmacol Soc 45: 118-124.
14. Hammouda Y, Rashid AK, Amer MS. 1964. Hypoglycaemic properties of tecomine and tecostanine. J Pharm Pharmacol 16: 833-834.
15. Howell L, Kochhar K, Saywell R, Zollinger T, Koehler J, Mandzuk C, Sutton B, Sevilla-Martir J, Allen D. 2006. Use of herbal remedies by hispanic patients: do they inform their physician?. J Am Board Fam Med 19: 566-578.
16. Ibáñez Camacho R, Román Ramos R. 1979. Efecto hypoglucemiante del nopal. Arch Invest Med 10: 224-230.
17. Instituto Nacional Indigenista (INI). 1994. Atlas de las Plantas de la Medicina Tradicional Mexicana: Argueta-Villamar, A; Cano-Asseleih, L:M; Rodarte, M.E., Eds. Vols. I, II and III. Instituto Nacional Indigenista, México: 1-1786.
18. Jia W, Gao W, Tang L. 2003. Antidiabetic herbal drugs officially approved in China. Phytother Res 17: 1127-1134.
19. Johnson L, Strich H, Taylor A, Timmermann B, Malone D, Teufel-Shone N, Drummond R, Woosley R, Pereira E, Martínez A. 2006. Use of herbal remedies by diabetic Hispanic women in the southwestern United States. Phytother Res 20: 250-255.
20. Keun OW, Ho LC, Sun LM, Young BE, Bae SC, Oh H, Yeon KB, Seong AJ. 2005. Antidiabetic effects of extracts from Psidium guajava. J Ethnopharmacol 96: 411-415.
21. King H, Aubert RE, Herman WH. 1998. Global burden of diabetes 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21: 1414-1431.
22. Leduc C, Coonishish J, Haddad P, Cuerrier A. 2005. Plants used by the Cree nation of Eeyou Istchee (Quebec, Canada) for the treatment of diabetes: a novel approach in quantitative ethnobotany. J Ethnopharmacol 105: 55-63.
23. López-Argáez N, Wacher HN, Kumate-Rodríguez J, Cruz M, Talavera J, Rivera-Arce E, Lozoya X. 2003. The use of complementary and alternative medicine therapies in type 2 diabetes patients in Mexico. Diabetes Care 26: 2470.
24. Lozoya X, Aguilar A, Camacho JR. 1987. Encuesta sobre el uso actual de plantas en la Medicina Tradicional Mexicana. Rev Med IMSS (Méx) 25:283-291.
25. Lwanga SK, Lemeshow S. 1991. Simple size determination in health studies. Geneva, Switzerland: World Health Organization.
26. nd. ed. Universidad Autónoma del Estado de Morelos, Comisión Nacional para el Conocimiento y Uso de la Biodiversidad.
27. Mukherjee PK, Maiti K, Mukherjee K, Houghton PJ. 2006. Leads from Indian medicinal plants with hypoglycemic potentials. J Ethnopharmacol 106: 1-28.
28. Otoom SA, Al-Safi SA, Kerem ZK, Alkofahi A. 2006. The use of herbs by diabetic Jordanian patients. J Herb Pharmacother 6: 31-34.
29. Pérez G, Ocegueda Z, Muñoz L, Avila A, Morrow W. 1984. A study of the hypoglucemic effect of some Mexican plants. J Ethnopharmacol 12: 253-262.
30. Román R, Flores S, Téllez B, Rivas B, Alarcón A. 2000. Estudio experimental de la acción antihiperglucemiante del nopal (Opuntia streptacantha Lemaire). Rev Hispanoam 5: 17-19.
31. Rull JA, Aguilar Salinas C, Rojas R, Ríos Torres JM, Gómez Pérez FJ, Olaíz G. 2005. Epidemiology of type 2 diabetes in Mexico. Arch Med Res 36: 188-196.
32. Tapsell LC, Hemphill, Cobiac L, Patch CS, Sullivan DR, Fenech M, Roodenrys S, Keogh JB, Clifton PM, Williams PG, Fazio VA, Inge KE. 2006. Health benefits of herbs and spices: the past, the present, the future. Med J Aust 185: S4-S24.
33. Universidad Autónoma del Estado de Morelos (UAEM). 2005. Topializtli Anenecuilcayotl. Plantas medicinales y medicina tradicional de Anenecuilco, Morelos. Gómez Mureddu G. Comp. Universidad Autónoma del Estado de Morelos, México: 367.
34. Wild S, Roglic G, Green A. 2004. Global prevalence of diabetes. Diabetes Care 27: 1047-1953.
35. Zenk SN, Shaver JL, Peragallo N, Fox P, Chávez N. 2001. Use of herbal therapies among midlife Mexican women. Health Care Women Int 22: 585-597.